You are here
Antiobiotics and children
Antibiotics save lives and are the foundation of modern medicine. They allow doctors to treat and prevent bacterial infections every day for thousands of children and provide safer surgeries, organ transplants, cancer treatments and intensive care. Despite their importance, every time a child receives antibiotics, whether appropriately or not, there is risk. For individuals, antibiotic use can cause side effects, prolonged hospital stays and longer-term health harms. For the broader community, antibiotic use drives the development of bacterial resistance, making it difficult, or even impossible to treat some infections. When antibiotics are overused, a particular problem in children, we are exposing them to avoidable risk. Australian children have one of the highest antibiotic use rates in the world. We need to act now and use antibiotics better in children. Using them appropriately will avoid harms and preserve them so we can safeguard the health and future of our children.
For every child to receive the best care possible through precision antibiotic therapy – delivering the right drug in the right way at the right dose at the right time and in the right place.
To establish a worldleading research program at the Melbourne Children’s campus that will revolutionise antibiotic use in children to reduce resistance and prevent long term harms.
MCRI’s Infection flagship
MCRI’s Infection flagship was established to tackle unanswered questions of global importance in clinical infectious diseases. Our first focus is antibiotic use in children, an area of research that has largely been neglected.
The fragmented nature of research in this area has left fundamental questions unanswered. To address these gaps, the highly successful clinician-researchers of the clinical Infectious Diseases team at The Royal Children’s Hospital have come together to lead the flagship.Leveraging the capacity and resources at MCRI and supported by our campus partner, The Royal Children’s Hospital Foundation, we are combining our clinical and research strengths to make an immediate impact and find solutions to big questions.
By tackling the big questions now, we will generate new knowledge about the best way to use antibiotics in children, which will be used to improve health and prevent harms for children around the world.
Our work will provide all children with access to the best treatments, underpinned by the best research, to enable the brightest and healthiest futures possible.